Showing results (1901-1910 of 2,129) with videos related to
Sort By:
Pageof 213
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 26, 2021
Estimates of future cancer mortality attributable to modifiable risk factors in CanadaJoy Pader, Yibing Ruan, Abbey E Poirier, et al.Oncogene|April 21, 2015
Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitorsV Gibaja, F Shen, J Harari, et al.British Journal of Clinical Pharmacology|July 19, 2012
Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitorGretchen Bain, Christopher D King, Kevin Schaab, et al.Aging Cell|May 27, 2025
Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Single-Blinded Randomized Placebo-Controlled Therapeutic Plasma ExchangeMatias Fuentealba, Dobri Kiprov, Kevin Schneider, et al.Bioorganic & Medicinal Chemistry Letters|November 2, 2005
The identification of potent and selective imidazole-based inhibitors of B-Raf kinaseAndrew K Takle, Murray J B Brown, Susannah Davies, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 1, 2017
Nasopharyngeal carcinoma: relationship between invasion of the prevertebral space and distant metastasesQi-Yong Ai, Chen-Wen Hu, Kunwar S Bhatia, et al.Molecular Pain|August 2, 2011
The Rat Grimace Scale: a partially automated method for quantifying pain in the laboratory rat via facial expressionsSusana G Sotocinal, Robert E Sorge, Austin Zaloum, et al.European Radiology|August 27, 2024
Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinomaQi Yong H Ai, Ann D King, Yip Man Tsang, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?Klodeta Kura, Wilma A Stolk, Maria-Gloria Basáñez, et al.Journal of Medicinal Chemistry|December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.Pageof 213